Human rights and modern slavery
We expect our employees and the third parties we work with to act according to our values – patient focus, integrity, respect for people and transparency, and we are committed to respecting internationally recognised human rights throughout our global operations.
we conducted our second corporate-level human rights risk assessment to ensure we are focusing efforts where our business has the greatest potential to impact people. This involved seeking input from internal and external stakeholders, including human rights experts, third party consultants and peer companies to learn from their perspectives, knowledge and experiences. The six priority areas below were identified.
We leverage our scientific expertise, partnerships and our global reach to improve the quality of life for patients around the world. This includes researching treatments and vaccines for neglected diseases, striving to make our medicines and vaccines accessible to everyone who needs them and investing in strengthening healthcare systems.
We recognise that our priority areas may change as our business grows and evolves over time. We will continue to deepen our understanding of the potential human rights impacts associated with our activities, strengthen the tools and processes to manage these areas and are committed to engaging in constructive dialogue with others regarding these issues.